Cancer Control in Central and Eastern Europe
نویسندگان
چکیده
منابع مشابه
Cancer Control in Central and Eastern Europe
In the last decade, cancer mortality has declined by approximately 1% per year in both sexes in most areas of the world, including higherand lower-income regions [1]. However, as remarked by Vrdoljak et al. [2], appreciable differences in cancer incidence and mortality persist throughout various areas of the world, including Europe. In the 1990s, after the end of nonmarket economies in most of ...
متن کاملMolecular Cancer Genetics in Eastern and Central Europe
Over the last 10 years 25 different hereditary cancer syndromes have been identified and attributed to specific germline mutations in various inherited cancer genes. Though hereditary cancer syndromes are rare, their investigation has begun to provide unprecedented insights into the molecular origin and pathogenesis of various forms of cancer [3]. With the cloning of cancer-predisposing genes i...
متن کاملCentral and Eastern Europe: Floods
affected persons in the Czech Republic, Poland, Slovakia and Hungary, was fully covered. The generous response of donors, backed up by a similar gesture from local communities, allowed all aspects of the operation (emergency relief, post-emergency relief, and rehabilitation) to be effected. Problems with communications and lack of Disaster Preparedness know-how were surmounted and valuable less...
متن کاملDevelopments in Central and Eastern Europe
This article highlights the tenth conference of the Alliance of Universities for Democracy (AUDEM) held in Budapest, Hungary. Over the past ten years, AUDEM members have been instrumental in the reform of higher education in Central and Eastern Europe based on democratic principles. This year, government officials, college administrators, faculty members, and academic librarians from around the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Oncologist
سال: 2016
ISSN: 1083-7159,1549-490X
DOI: 10.1634/theoncologist.2016-0230